Cookie Preference

This website uses cookies to improve user experience. Please select an option.  Privacy Policy

No cookies except for those necessary for technical reasons are set.

Search

Search results

HepaRegeniX has demonstrated proof-of-efficacy in acute liver disease in preclinical studies performed in collaboration with the University Hospital of Tübingen (Germany) and the Mayo Clinic (Rochester, MN, USA).

[Translate to English:]

Newly founded dentalXrai provides a unique, AI-based platform to improve and speed up the analysis of dental X-ray images. Ascenion, technology transfer partner of the Charité – Universitätsmedizin Berlin, holds equity in the start-up.

[Translate to English:]

Diffratec, a spin-off from the Medical University of Innsbruck (MUI), commercializes breakthrough diffractive elements. These elements, in particular Moiré lenses, are extremely compact and tunable with high speed and precision.

Ascenion and Innovationsstarter Fonds Hamburg acquire equity in Hamburg start-up – innovative therapeutic approach enters clinical testing

Only a few places left! Register now for the 13th Biotech NetWorkshop, 5–7 February 2020 in Schloss Ringberg.

Don’t miss your chance to secure a spot at next year’s BioVaria, 27 – 28 April 2020 in Munich! Application for European startups is now open until 14t…

Should public research institutes and universities receive equity in start-ups founded to commercialize their intellectual property? And if so, how…

Ascenion’s portfolio company Berlin Cures has initiated a Phase IIa clinical study with its lead compound BC 007. The two-armed, randomized,…

Simultaneously Closes Strategic Growth Investment from Ampersand Capital to Create a Leading Provider of Genomic and Cell and Tissue Analysis Products…

BioVaria brings together Europe’s top scientists and technology transfer professionals with potential licensees and investors from the international…

Ascenion’s portfolio company OMEICOS dosed a first patient in a Phase II clinical trial for its lead program OMT-28. The placebo-controlled,…

This is an exciting opportunity for European healthcare entrepreneurs, start-ups and SMEs: EIT Health invites you to apply for participation in the…

Technology sneak peek from Ascenion: Seven breakthrough life-science inventions                                      

12 March 2019, Munich, Germany…

BioVaria is organised by Ascenion and several other technology transfer organisations from all across Europe. The conference brings together Europe’s…

Clinicians and scientists from the Medical University Innsbruck (MUI) and the University of Innsbruck have developed an innovative urine test to…

Don’t miss your chance to secure a spot at next year’s BioVaria, 8 - 9 May 2019 in Munich! Application for European startups is now open until 1st

iThera Medical, a spin-off from the Helmholtz Zentrum München, has closed series C financing with new investors FLUXUNIT, the corporate venture…

In April, the members of the rapidly growing TechnologieAllianz e.V. teamed up with founders, investors, scientists and politicians for the 3rd…

This year’s BioVaria was the event in 2018 for early-stage, life-science European startups to connect with investors, with a record number of company…

Startup Awards go to OPSYON and LIfT Biosciences

26 April 2018, Munich, Germany – Over 250 innovative minds gathered in Munich on April 23-24 for the…

Berlin Cures, one of Ascenion’s portfolio companies, has announced positive Phase I results for its lead candidate BC007 for the treatment of heart…

BioVaria brings together Europe’s top scientists and technology transfer professionals with potential licensees and investors from the international…

Join over 400 experts in medical innovation to discuss global challenges and pioneering technologies in healthcare. During two conference days, you…

Technology sneak peek from Ascenion: Five breakthrough life-science inventions

9 March 2018, Munich, Germany – On 23–24 April 2018, decision makers…

Don’t miss your chance to secure a spot at BioVaria on 23./24. April 2018 to pitch your company to leading investors and biopharmaceutical decision…

Around thirty startup founders and aspiring entrepreneurs met in Munich during this year’s Biotech NetWorkshop to learn from drug development experts…

BioVaria Spin-off Awards go to Captain T Cell and Provirex

24 May 2017, Munich, Germany – On 22–23 May 2017, over 180 innovative minds gathered in…

Join Europe’s leading showcase for life-science inventions!

Ascenion is proud to present a strong line-up of speakers, participants and technologies…

Network with your peers, seasoned entrepreneurs and industry experts to gain valuable feedback on how to improve your project’s chances of success in…

Technology Sneak Peek from Ascenion: Human T-cell receptors for cancer therapy

4 April 2017, Munich, Germany – On 22-23 May 2017, dealmakers from…

This year’s BioVaria Anniversary Edition will, for the first time, extend over two days and include the promising field of digital health. Top-tier…

Around 40 commercially attractive, licensable technologies that were presented at this year’s BioVaria are now available online – including videos of…

BioVaria Spin-off Awards go to Charité spin-off and Braingineering Technologies

19 May 2016, Munich, Germany – Dealmakers and investors from the…

Join Europe’s leading market place for life-science inventions!

Ascenion unveils technology highlights: New approaches for the treatment of neurodegenerative disorders and glioblastoma

BioVaria is designed for dealmakers and investors from the global life-science sector responsible for identifying, licensing or funding break-through…